Open Access. Powered by Scholars. Published by Universities.®

Physical Sciences and Mathematics Commons

Open Access. Powered by Scholars. Published by Universities.®

PDF

Australian Institute for Innovative Materials - Papers

Cancer

Publication Year

Articles 1 - 3 of 3

Full-Text Articles in Physical Sciences and Mathematics

Stimulus-Dependent Differences In Signalling Regulate Epithelial-Mesenchymal Plasticity And Change The Effects Of Drugs In Breast Cancer Cell Lines, Joseph Cursons, Karl-Johan Leuchowius, Mark Waltham, Eva Tomaskovic-Crook, Momeneh Foroutan, Cameron P. Bracken, Andrew Redfern, Edmund J. Crampin, Ian Street, Melissa J. Davis, Erik W. Thompson Jan 2015

Stimulus-Dependent Differences In Signalling Regulate Epithelial-Mesenchymal Plasticity And Change The Effects Of Drugs In Breast Cancer Cell Lines, Joseph Cursons, Karl-Johan Leuchowius, Mark Waltham, Eva Tomaskovic-Crook, Momeneh Foroutan, Cameron P. Bracken, Andrew Redfern, Edmund J. Crampin, Ian Street, Melissa J. Davis, Erik W. Thompson

Australian Institute for Innovative Materials - Papers

Introduction: The normal process of epithelial mesenchymal transition (EMT) is subverted by carcinoma cells to facilitate metastatic spread. Cancer cells rarely undergo a full conversion to the mesenchymal phenotype, and instead adopt positions along the epithelial-mesenchymal axis, a propensity we refer to as epithelial mesenchymal plasticity (EMP). EMP is associated with increased risk of metastasis in breast cancer and consequent poor prognosis. Drivers towards the mesenchymal state in malignant cells include growth factor stimulation or exposure to hypoxic conditions.

Methods: We have examined EMP in two cell line models of breast cancer: the PMC42 system (PMC42-ET and PMC42-LA …


Synthesis Of Potential Theranostic System Consisting Of Methotrexate-Immobilized (3-Aminopropyl)Trimethoxysilane Coated Α-Bi2o3 Nanoparticles For Cancer Treatment, Kathrin Bogusz, Moeava Tehei, Callum Stewart, Marjorie Mcdonald, Dean Cardillo, Michael Lerch, Stephanie Corde, Anatoly Rosenfeld, Hua-Kun Liu, Konstantin Konstantinov Jan 2014

Synthesis Of Potential Theranostic System Consisting Of Methotrexate-Immobilized (3-Aminopropyl)Trimethoxysilane Coated Α-Bi2o3 Nanoparticles For Cancer Treatment, Kathrin Bogusz, Moeava Tehei, Callum Stewart, Marjorie Mcdonald, Dean Cardillo, Michael Lerch, Stephanie Corde, Anatoly Rosenfeld, Hua-Kun Liu, Konstantin Konstantinov

Australian Institute for Innovative Materials - Papers

In this study we present the synthesis of a new theranostic system consisting of a core-shell structured nanoceramic-drug conjugate that can potentially combine chemotherapeutic, targeting, diagnostic and radio dose enhancing features in cancer treatment. The conjugate is made of α-Bi2O3 nanoparticles (NPs) which were first coated with (3-aminopropyl)trimethoxysilane (APTMS) to form a core-shell structure and then attached with methotrexate (MTX) through amidation between the amine moieties on the shell and the carboxylic acid groups on MTX. While α-Bi2O3 NPs with high effective atomic number can serve as both contrast agent and radiosensitiser in dose enhancement radiation therapy, MTX as an …


Epithelial To Mesenchymal Transition And Breast Cancer, Eva Tomaskovic-Crook, Erik W. Thompson, Jean Paul Thiery Jan 2009

Epithelial To Mesenchymal Transition And Breast Cancer, Eva Tomaskovic-Crook, Erik W. Thompson, Jean Paul Thiery

Australian Institute for Innovative Materials - Papers

Epithelial-mesenchymal plasticity in breast carcinoma encompasses the phenotypic spectrum whereby epithelial carcinoma cells within a primary tumor acquire mesenchymal features and re-epithelialize to form a cohesive secondary mass at a metastatic site. Such plasticity has implications in progression of breast carcinoma to metastasis, and will likely influence response to therapy. The transcriptional and epigenetic regulation of molecular and cellular processes that underlie breast cancer and result in characteristic changes in cell behavior can be monitored using an increasing array of marker proteins. Amongst these markers exists the potential for emergent prognostic, predictive and therapeutic targeting.